Shahzad Shaefi, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oxygen Inhalation Therapy | 4 | 2021 | 418 | 1.570 |
Why?
|
Cardiac Surgical Procedures | 16 | 2023 | 3684 | 1.440 |
Why?
|
Extracorporeal Membrane Oxygenation | 6 | 2023 | 1483 | 1.030 |
Why?
|
Hyperoxia | 2 | 2018 | 261 | 1.010 |
Why?
|
Oxygen | 6 | 2022 | 4270 | 0.990 |
Why?
|
Respiratory Insufficiency | 6 | 2023 | 1240 | 0.900 |
Why?
|
Methyl Ethers | 2 | 2022 | 196 | 0.900 |
Why?
|
Anesthetics, Inhalation | 3 | 2022 | 573 | 0.810 |
Why?
|
Propofol | 4 | 2022 | 608 | 0.790 |
Why?
|
Coronary Artery Bypass | 6 | 2019 | 2191 | 0.760 |
Why?
|
Cardiopulmonary Bypass | 6 | 2022 | 1097 | 0.710 |
Why?
|
Isoflurane | 1 | 2022 | 384 | 0.640 |
Why?
|
Intraoperative Care | 2 | 2021 | 770 | 0.630 |
Why?
|
Tidal Volume | 3 | 2018 | 518 | 0.620 |
Why?
|
Resource Allocation | 1 | 2020 | 354 | 0.600 |
Why?
|
Respiration, Artificial | 7 | 2023 | 2726 | 0.580 |
Why?
|
Vasoplegia | 1 | 2017 | 15 | 0.580 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 384 | 0.540 |
Why?
|
Delirium | 7 | 2023 | 1696 | 0.530 |
Why?
|
Critical Illness | 10 | 2023 | 2755 | 0.520 |
Why?
|
Thoracic Wall | 1 | 2018 | 204 | 0.510 |
Why?
|
Thoracic Surgery | 1 | 2022 | 727 | 0.490 |
Why?
|
Anesthesiology | 2 | 2022 | 1137 | 0.470 |
Why?
|
Hospital Mortality | 10 | 2021 | 5349 | 0.470 |
Why?
|
Acute Lung Injury | 1 | 2018 | 378 | 0.450 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1508 | 0.440 |
Why?
|
Critical Care | 5 | 2023 | 2715 | 0.420 |
Why?
|
Intensive Care Units | 12 | 2021 | 3800 | 0.400 |
Why?
|
Monitoring, Intraoperative | 2 | 2017 | 948 | 0.380 |
Why?
|
Postoperative Care | 1 | 2018 | 1480 | 0.380 |
Why?
|
Tissue Plasminogen Activator | 3 | 2021 | 1165 | 0.370 |
Why?
|
Shock, Cardiogenic | 2 | 2022 | 711 | 0.350 |
Why?
|
Cost of Illness | 1 | 2020 | 1951 | 0.350 |
Why?
|
Surgical Procedures, Operative | 2 | 2020 | 1933 | 0.340 |
Why?
|
Dexmedetomidine | 3 | 2019 | 320 | 0.340 |
Why?
|
Prone Position | 3 | 2021 | 203 | 0.320 |
Why?
|
Bronchoscopy | 4 | 2020 | 914 | 0.310 |
Why?
|
Pandemics | 7 | 2021 | 8747 | 0.310 |
Why?
|
Anesthesia | 5 | 2019 | 1596 | 0.300 |
Why?
|
Patient Positioning | 3 | 2021 | 332 | 0.280 |
Why?
|
Postoperative Complications | 11 | 2023 | 15833 | 0.260 |
Why?
|
Lung Injury | 2 | 2022 | 433 | 0.260 |
Why?
|
Cognition | 5 | 2020 | 7073 | 0.260 |
Why?
|
Analgesics, Non-Narcotic | 2 | 2019 | 371 | 0.250 |
Why?
|
Hypnotics and Sedatives | 3 | 2019 | 1191 | 0.240 |
Why?
|
Positive-Pressure Respiration | 3 | 2018 | 713 | 0.230 |
Why?
|
Acetaminophen | 2 | 2019 | 552 | 0.230 |
Why?
|
Physicians | 1 | 2022 | 4598 | 0.230 |
Why?
|
Humans | 77 | 2024 | 768171 | 0.220 |
Why?
|
Perioperative Care | 3 | 2020 | 1043 | 0.210 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2023 | 425 | 0.210 |
Why?
|
Coronary Artery Disease | 3 | 2018 | 6568 | 0.210 |
Why?
|
Aged | 30 | 2023 | 171502 | 0.180 |
Why?
|
Length of Stay | 5 | 2022 | 6498 | 0.180 |
Why?
|
Martial Arts | 1 | 2021 | 29 | 0.180 |
Why?
|
Thrombosis | 3 | 2021 | 2957 | 0.180 |
Why?
|
Midodrine | 1 | 2020 | 24 | 0.180 |
Why?
|
Treatment Outcome | 17 | 2021 | 65379 | 0.180 |
Why?
|
Male | 39 | 2023 | 364731 | 0.180 |
Why?
|
Coronary Artery Bypass, Off-Pump | 2 | 2018 | 65 | 0.170 |
Why?
|
Female | 38 | 2023 | 397187 | 0.160 |
Why?
|
Time | 1 | 2021 | 552 | 0.160 |
Why?
|
Hospitalization | 5 | 2021 | 10840 | 0.160 |
Why?
|
Sepsis | 3 | 2019 | 2608 | 0.150 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3115 | 0.150 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2022 | 223 | 0.150 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3238 | 0.150 |
Why?
|
Double-Blind Method | 4 | 2021 | 12466 | 0.150 |
Why?
|
Middle Aged | 31 | 2023 | 223487 | 0.150 |
Why?
|
Partial Pressure | 1 | 2017 | 248 | 0.150 |
Why?
|
Blood Coagulation Disorders | 1 | 2021 | 350 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.140 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2785 | 0.140 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 92 | 0.140 |
Why?
|
Methylene Blue | 1 | 2017 | 156 | 0.140 |
Why?
|
Cohort Studies | 12 | 2023 | 41753 | 0.140 |
Why?
|
Heme Oxygenase-1 | 1 | 2019 | 365 | 0.140 |
Why?
|
Intubation, Intratracheal | 2 | 2019 | 1359 | 0.140 |
Why?
|
Apyrase | 1 | 2019 | 376 | 0.140 |
Why?
|
Boston | 6 | 2020 | 9374 | 0.130 |
Why?
|
Tracheostomy | 1 | 2020 | 430 | 0.130 |
Why?
|
Respiration Disorders | 1 | 2019 | 364 | 0.130 |
Why?
|
Hospitals, Community | 1 | 2018 | 365 | 0.130 |
Why?
|
United States | 13 | 2023 | 73039 | 0.130 |
Why?
|
Brain Injuries | 2 | 2018 | 2057 | 0.130 |
Why?
|
Aneurysm, Ruptured | 1 | 2021 | 455 | 0.130 |
Why?
|
Meditation | 1 | 2019 | 257 | 0.120 |
Why?
|
Ethics, Medical | 1 | 2020 | 785 | 0.120 |
Why?
|
Anesthetics | 1 | 2021 | 525 | 0.120 |
Why?
|
Surgery, Computer-Assisted | 1 | 2003 | 1003 | 0.120 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15949 | 0.120 |
Why?
|
Intracranial Pressure | 1 | 2017 | 323 | 0.120 |
Why?
|
Frail Elderly | 1 | 2020 | 781 | 0.120 |
Why?
|
Myocardial Revascularization | 1 | 2018 | 795 | 0.120 |
Why?
|
Angiotensin II | 1 | 2017 | 844 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 718 | 0.120 |
Why?
|
Burnout, Professional | 1 | 2023 | 711 | 0.120 |
Why?
|
Hypotension | 1 | 2020 | 888 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1141 | 0.110 |
Why?
|
Pneumothorax | 1 | 2017 | 393 | 0.110 |
Why?
|
Medicare | 2 | 2023 | 6809 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2023 | 10397 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2021 | 1422 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 984 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1854 | 0.100 |
Why?
|
Adult | 23 | 2023 | 223646 | 0.100 |
Why?
|
Lung | 4 | 2020 | 10101 | 0.100 |
Why?
|
Hospitals, Urban | 1 | 2015 | 497 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3912 | 0.100 |
Why?
|
Catheterization, Central Venous | 1 | 2017 | 537 | 0.100 |
Why?
|
Conscious Sedation | 2 | 2014 | 534 | 0.100 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2019 | 1566 | 0.100 |
Why?
|
Deep Sedation | 1 | 2013 | 119 | 0.100 |
Why?
|
Clinical Protocols | 1 | 2017 | 1443 | 0.100 |
Why?
|
Neurosurgical Procedures | 1 | 2003 | 2077 | 0.100 |
Why?
|
Prospective Studies | 7 | 2022 | 54924 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2055 | 0.090 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1292 | 0.090 |
Why?
|
Heart Diseases | 1 | 2024 | 2819 | 0.090 |
Why?
|
Intracranial Aneurysm | 1 | 2021 | 1271 | 0.090 |
Why?
|
Time Factors | 8 | 2020 | 40220 | 0.090 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2211 | 0.090 |
Why?
|
Weight Gain | 1 | 2021 | 2359 | 0.090 |
Why?
|
Terrorism | 1 | 2013 | 211 | 0.090 |
Why?
|
Heart Arrest | 1 | 2020 | 1515 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2163 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2020 | 1176 | 0.090 |
Why?
|
Aged, 80 and over | 11 | 2022 | 59626 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1807 | 0.080 |
Why?
|
Risk Factors | 13 | 2020 | 74944 | 0.080 |
Why?
|
Preoperative Care | 1 | 2019 | 2258 | 0.080 |
Why?
|
Klippel-Feil Syndrome | 1 | 2009 | 19 | 0.080 |
Why?
|
Weight Loss | 1 | 2021 | 2721 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1524 | 0.080 |
Why?
|
Registries | 3 | 2021 | 8375 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9613 | 0.080 |
Why?
|
Anticoagulants | 2 | 2021 | 4850 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2023 | 81760 | 0.070 |
Why?
|
Nephrectomy | 1 | 2012 | 930 | 0.070 |
Why?
|
Epilepsy | 1 | 2003 | 3326 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1944 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2517 | 0.070 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2725 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3384 | 0.070 |
Why?
|
Hemodynamics | 1 | 2017 | 4194 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4648 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4260 | 0.060 |
Why?
|
Logistic Models | 3 | 2019 | 13290 | 0.060 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2654 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3643 | 0.060 |
Why?
|
Anxiety | 2 | 2019 | 4672 | 0.060 |
Why?
|
Hospitals | 2 | 2019 | 3886 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39354 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3857 | 0.060 |
Why?
|
Cytokines | 1 | 2020 | 7452 | 0.060 |
Why?
|
Risk Assessment | 4 | 2020 | 24318 | 0.060 |
Why?
|
Deafness | 1 | 2009 | 460 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12077 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14783 | 0.060 |
Why?
|
Aortic Aneurysm | 1 | 2009 | 649 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2020 | 5315 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7454 | 0.050 |
Why?
|
Laryngoscopy | 1 | 2009 | 714 | 0.050 |
Why?
|
Body Mass Index | 1 | 2021 | 13053 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5520 | 0.050 |
Why?
|
Embolization, Therapeutic | 1 | 2012 | 1401 | 0.050 |
Why?
|
Stroke Volume | 1 | 2016 | 5622 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 30009 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16726 | 0.050 |
Why?
|
Intraoperative Complications | 1 | 2009 | 1171 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6209 | 0.050 |
Why?
|
Anesthesia, General | 1 | 2009 | 1189 | 0.050 |
Why?
|
Cardiac Imaging Techniques | 1 | 2024 | 280 | 0.050 |
Why?
|
Young Adult | 6 | 2021 | 60066 | 0.050 |
Why?
|
Fibrinolytic Agents | 2 | 2021 | 2080 | 0.050 |
Why?
|
Databases, Factual | 2 | 2015 | 8080 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 204 | 0.050 |
Why?
|
Glasgow Coma Scale | 1 | 2022 | 574 | 0.040 |
Why?
|
Athletic Performance | 1 | 2021 | 113 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2021 | 224 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2006 | 1724 | 0.040 |
Why?
|
Hemorrhage | 2 | 2021 | 3466 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2022 | 397 | 0.040 |
Why?
|
Depression | 1 | 2019 | 8230 | 0.040 |
Why?
|
Adolescent | 6 | 2021 | 89169 | 0.040 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1942 | 0.040 |
Why?
|
Survival Rate | 3 | 2021 | 12840 | 0.040 |
Why?
|
Coma | 1 | 2022 | 485 | 0.040 |
Why?
|
Thrombophilia | 1 | 2021 | 308 | 0.040 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 223 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1755 | 0.040 |
Why?
|
Age Factors | 4 | 2020 | 18415 | 0.040 |
Why?
|
Intermittent Positive-Pressure Ventilation | 1 | 2017 | 15 | 0.040 |
Why?
|
Catheterization | 1 | 2023 | 1430 | 0.040 |
Why?
|
Workflow | 1 | 2023 | 860 | 0.040 |
Why?
|
Air Pressure | 1 | 2017 | 75 | 0.040 |
Why?
|
Aerosols | 1 | 2020 | 634 | 0.040 |
Why?
|
Heme | 1 | 2019 | 316 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2012 | 3187 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2021 | 587 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 656 | 0.030 |
Why?
|
California | 1 | 2021 | 1438 | 0.030 |
Why?
|
Australia | 1 | 2020 | 1265 | 0.030 |
Why?
|
Plasma | 1 | 2020 | 585 | 0.030 |
Why?
|
Lung Volume Measurements | 1 | 2017 | 381 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2020 | 459 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2020 | 947 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13586 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4282 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2009 | 3007 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 1008 | 0.030 |
Why?
|
Airway Obstruction | 1 | 2020 | 672 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1864 | 0.030 |
Why?
|
Long-Term Care | 1 | 2019 | 631 | 0.030 |
Why?
|
Patient Care Team | 2 | 2020 | 2523 | 0.030 |
Why?
|
Adenosine | 1 | 2019 | 822 | 0.030 |
Why?
|
Echocardiography | 2 | 2017 | 5047 | 0.030 |
Why?
|
Eating | 1 | 2021 | 1542 | 0.030 |
Why?
|
Holidays | 1 | 2013 | 41 | 0.030 |
Why?
|
Ultrasonography | 2 | 2020 | 6004 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9669 | 0.030 |
Why?
|
Supine Position | 1 | 2014 | 208 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2149 | 0.030 |
Why?
|
Laser Therapy | 1 | 2020 | 1107 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2004 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2649 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21538 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2007 | 3980 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 621 | 0.030 |
Why?
|
Sleep | 2 | 2019 | 4818 | 0.030 |
Why?
|
Premedication | 1 | 2013 | 246 | 0.030 |
Why?
|
Operating Rooms | 1 | 2019 | 790 | 0.030 |
Why?
|
Survival Analysis | 2 | 2021 | 10099 | 0.020 |
Why?
|
Sex Factors | 2 | 2021 | 10632 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1886 | 0.020 |
Why?
|
Leisure Activities | 1 | 2013 | 310 | 0.020 |
Why?
|
Fenoldopam | 1 | 2011 | 6 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26379 | 0.020 |
Why?
|
Comorbidity | 2 | 2020 | 10590 | 0.020 |
Why?
|
Affect | 1 | 2019 | 1495 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4355 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2017 | 1321 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4861 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2022 | 3841 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2697 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1969 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2911 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5902 | 0.020 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2017 | 1024 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2998 | 0.020 |
Why?
|
Bronchoscopes | 1 | 2009 | 64 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6316 | 0.020 |
Why?
|
Hemolysis | 1 | 2011 | 417 | 0.020 |
Why?
|
Optical Fibers | 1 | 2009 | 135 | 0.020 |
Why?
|
Renal Replacement Therapy | 1 | 2011 | 282 | 0.020 |
Why?
|
Stents | 1 | 2020 | 3197 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1238 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1882 | 0.020 |
Why?
|
Trauma Centers | 1 | 2013 | 951 | 0.020 |
Why?
|
Laryngoscopes | 1 | 2009 | 147 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3490 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2019 | 3080 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9755 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12543 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2011 | 1194 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7140 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4091 | 0.020 |
Why?
|
Patient Discharge | 1 | 2019 | 3479 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8890 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8741 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15453 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22290 | 0.010 |
Why?
|
Mental Health | 1 | 2019 | 3275 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2016 | 2057 | 0.010 |
Why?
|
Colectomy | 1 | 2009 | 696 | 0.010 |
Why?
|
Patient Care Planning | 1 | 2009 | 905 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 979 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3837 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20225 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 30255 | 0.010 |
Why?
|
Glucose | 1 | 2011 | 4352 | 0.010 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2009 | 1417 | 0.010 |
Why?
|
Clinical Competence | 1 | 2013 | 4858 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13490 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36741 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3251 | 0.010 |
Why?
|
Kidney | 1 | 2011 | 7064 | 0.010 |
Why?
|
Regression Analysis | 1 | 2003 | 6340 | 0.010 |
Why?
|
Blood Pressure | 1 | 2009 | 8543 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2009 | 5176 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 14164 | 0.000 |
Why?
|
Animals | 1 | 2019 | 169285 | 0.000 |
Why?
|